Monoclonal Antibody Biosimilars

The first mAb biosimilars to be approved in Europe and elsewhere was the infliximab biosimilars (Inflectra and Remsima), which originator is Remicade. In October 2013, after the European Medicines Agency (EMA) gave a positive opinion for infliximab biosimilars, the European Commission granted a marketing authorization (MA) for these two biosimilars in the various therapeutic indications that are authorized for Remicade (i.e. indications in gastroenterology, rheumatology, and dermatology). As for previously approved biosimilars, the two aforementioned European institutions did not make a stand on the issues of substitution, and with good reason, as answering these questions does not fall within their areas of expertise and is the sole responsibility of EU Member States.

    Related Conference of Monoclonal Antibody Biosimilars

    August 18-19, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    August 27-28, 2025

    20th World Congress on Drug Formulation & Drug Delivery

    Amsterdam, Netherlands
    September 19-20, 2025

    18th World Drug Delivery Summit

    Paris, France
    September 22-23, 2025

    Pharma Biotech Expo

    Toronto, Canada
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    September 24-25, 2025

    5th World Congress on Rare Diseases & Orphan Drugs

    Aix-en-Provence, France
    October 23-24, 2025

    21st Annual Meet on Pharmaceutical Sciences

    Aix-en-Provence, France
    November 11-12, 2025

    6th Annual Congress on Antibiotics and Bacterial Infections

    Amsterdam, Netherlands
    November 13-14, 2025

    21st International Conference on Pharmaceutical Chemistry

    Aix-en-Provence, France
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Paris, France
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    December 01-02, 2025

    13th International Conference on Clinical Trials

    Vancouver, Canada
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, Aland Islands
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 21-22, 2026

    8th International Conference and Exhibition on Pain Management

    Aix-en-Provence, France

    Monoclonal Antibody Biosimilars Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in